Logo Image

Video Shorts

Erika Hamilton, MD
1:16
Highlighting the FDA Approval of Maintenance Tucatinib-Based Therapy in Advanced HER2+ Breast Cancer
a day ago
by
Erika P. Hamilton, MD
Vincent Chung, MD
0:53
Spotlighting the Potential Future of Pancreatic Cancer Combination Regimens
2 days ago
by
Vincent Chung, MD
Brian M. Wolpin, MD, MPH
1:24
Highlighting Daraxonrasib’s Survival Benefit in Metastatic Pancreatic Cancer
2 days ago
by
Brian M. Wolpin, MD, MPH
Binod Dhakal, MD
1:19
The Potential Utility of Allogeneic CAR T-Cell Therapy in Myeloma
2 days ago
by
Binod Dhakal, MD
Alexis Ann LeVee, MD
2:03
Previewing the lidERA Trial PRO Data Being Presented at ESMO 2026
3 days ago
by
Alexis LeVee, MD
Kevin Kalinsky, MD, MS, FASCO
2:11
Previewing Breast Cancer Insights Expected at ESMO 2026
6 days ago
by
Kevin Kalinsky, MD, MS
Milana V. Dolezal, MD
2:06
Exploring Changes in First-Line Treatment for HER2-Positive Breast Cancer
8 days ago
by
Milana Dolezal, MD, MSci
Matthew Kurian, MD
2:04
Emphasizing the Importance of Vigilance When Using AI in Oncology
8 days ago
by
Matthew Kurian, MD
Leo Rasche, MD
1:15
Exploring Talquetamab-Based Therapy Before Transplant in Multiple Myeloma
9 days ago
by
Leo Rasche, MD
Sagar Lonial, MD, FACP, FASCO
1:25
Examining Iberdomide Plus Daratumumab/Dexamethasone in R/R Multiple Myeloma
9 days ago
by
Sagar Lonial, MD, FACP, FASCO
IMS 2026
2:26
What Will it Take to Use the Word Cure in Myeloma?
12 days ago
by
Riley Kandel(+4 more)
C. Ola Landgren, MD, PhD
3:06
Ranking New Myeloma Treatments With C. Ola Landgren, MD, PhD
13 days ago
by
C. Ola Landgren, MD, PhD
Rebecca Brown, MD
1:12
Explaining How Brigatinib May Work in Schwannomatosis
14 days ago
by
Rebecca Brown, MD, PhD
Naseema Gangat, MBBS
0:47
Breaking Down the Significance of DISC-3405 in Polycythemia Vera
14 days ago
by
Naseema Gangat, MBBS
Erica L. Mayer, MD, MPH
0:36
Highlighting the FDA Approval of Camizestrant for Emergent ESR1-Mutated Breast Cancer
15 days ago
by
Erica L. Mayer, MD, MPH
Matthew Kurian, MD, of St. Elizabeth Healthcare and the University of Kentucky College of Medicine
1:44
Weighing the Benefits and Limitations of AI Tools in Breast Oncology
16 days ago
by
Matthew Kurian, MD
Alexander Drilon, MD
0:53
Alexander Drilon, MD, Discusses Human Touch in Cancer Care
21 days ago
by
Alexander Drilon, MD
Byoung Chul Cho, MD, PhD
0:53
Learning Korean at BTG Lung in Seoul!
23 days ago
by
Byoung Chul Cho, MD, PhD
Chris Grant, MD
1:35
What's One Thing Your Patients Have Taught You?
24 days ago
by
Chris Grant, MD
WCLC 2026
1:44
Human Touch in Cancer Care
25 days ago
by
Riley Kandel(+1 more)
SOHO 2026
1:38
SOHO 2026 RECAP
a month ago
by
Riley Kandel(+1 more)
Stephen V. Liu, MD
1:04
Treatment for Locally Advanced Stage IIIA, ALK+ NSCLC
a month ago
by
Stephen Liu, MD
On an episode of Two Onc Docs, hosts Samantha A. Armstrong, MD, and Karine Tawagi, MD, summarize best practices for early-stage and locally advanced non–small cell lung cancer staging and management.
1:16
Spotlighting Best Practices for NSCLC Staging and Management
a month ago
by
Karine Tawagi, MD(+1 more)
On an episode of Breast Cancer Briefing, guest Dana Bonaminio, MD, shares why individualized breast cancer risk assessment should determine when a patient's first mammogram happens.
1:14
Highlighting the Importance of Individualized Breast Cancer Screening Practices
a month ago
by
Sara Nunnery, MD, MSCI(+1 more)
Andrew Kuykendall, MD, of Moffitt Cancer Center, ranks novel MPN treatments at the 2026 SOHO Annual Meeting.
2:18
Ranking Novel MPN Treatments at SOHO 2026
a month ago
by
Andrew Kuykendall, MD(+1 more)
Catch OncLive On the Ground at SOHO and WCLC 2026!
0:26
Catch OncLive On the Ground at SOHO and WCLC 2026!
a month ago
by
Riley Kandel
Charles E. Geyer, MD
1:20
Noting ILD/Radiation Pneumonitis Outcomes From DESTINY-Breast05
a month ago
by
Charles E. Geyer, MD
Chronic Neutropenia
1:13
Exploring Mavorixafor in Chronic Neutropenia Management
a month ago
by
David Sykes, MD, PhD
Aaron Gerds, MD, MS, breaks down considerations for selecting a JAK inhibitor in the treatment of patients with myelofibrosis.
1:33
Selecting a JAK Inhibitor in Myelofibrosis
a month ago
by
Aaron Gerds, MD, MS
Midhun Malla, MD
1:36
Spotlighting the Importance of Biomarker Testing in GI Cancer
a month ago
by
Midhun Malla, MD